The effect of Gaviscon on acid reflux episodes and on the position of the gastric acid pocket: A Scintigraphic study

The effect of Gaviscon on acid reflux episodes and on the position of the gastric acid pocket: A Scintigraphic study - Gaviscon and Acid pocket

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON35613

Enrollment

Registered

2011-11-08

Start date

2012-01-01

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal reflux disease heartburn

Interventions

Oral administration of 10 mL Gaviscon

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - GERD confirmed by pH-impedance (ph4,5 % of time or positive symptom association), or in patients with reflux esophagitis - Written informed consent - 18-75 years;

Exclusion criteria

Exclusion criteria: - surgery of the gastrointestinal tract other then appendectomy - inability to stop the use of proton pump inhibitors for one week; - participation in another study with exposure to radiation within the last year; - long segment of Barrett*s epithelium;

Design outcomes

Primary

Measure	Time frame
- Acid reflux episodes	—

Secondary

Measure	Time frame
- Postprandial esophageal acid exposure - The rate of acid versus non acid reflux events - Non acid reflux events - The position of the acid pocket, relative to the crural diaphragm	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)